These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34536730)

  • 1. The role of transforming growth factor β in upper gastrointestinal cancers: A systematic review.
    Veen LM; Skrabanja TLP; Derks S; de Gruijl TD; Bijlsma MF; van Laarhoven HWM
    Cancer Treat Rev; 2021 Nov; 100():102285. PubMed ID: 34536730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
    Altorki N; Schwartz GK; Blundell M; Davis BM; Kelsen DP; Albino AP
    Cancer; 1993 Aug; 72(3):649-57. PubMed ID: 8334620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage coculture enhanced invasion of gastric cancer cells via TGF-β and BMP pathways.
    Shen Z; Kauttu T; Cao J; Seppänen H; Vainionpää S; Ye Y; Wang S; Mustonen H; Puolakkainen P
    Scand J Gastroenterol; 2013 Apr; 48(4):466-72. PubMed ID: 23517295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.
    Souza RF; Garrigue-Antar L; Lei J; Yin J; Appel R; Vellucci VF; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Reiss M; Meltzer SJ
    Hum Cell; 1996 Sep; 9(3):229-36. PubMed ID: 9183654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Asarone suppresses TGF-β/Smad signaling to reduce the invasive properties in esophageal squamous cancer cells.
    Hu Y; Li Z; Gong L; Song Z
    Med Oncol; 2022 Sep; 39(12):243. PubMed ID: 36180656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
    Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
    J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1999 Oct; 86(8):1455-62. PubMed ID: 10526273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
    Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PRAJA and ELF in TGF-beta signaling and gastric cancer.
    Mishra L; Katuri V; Evans S
    Cancer Biol Ther; 2005 Jul; 4(7):694-9. PubMed ID: 16096365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-beta1.
    Wang KS; Hu ZL; Li JH; Xiao DS; Wen JF
    Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):179-86. PubMed ID: 16518542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma.
    Fukai Y; Fukuchi M; Masuda N; Osawa H; Kato H; Nakajima T; Kuwano H
    Int J Cancer; 2003 Mar; 104(2):161-6. PubMed ID: 12569570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33.
    Kim AH; Lebman DA; Dietz CM; Snyder SR; Eley KW; Chung TD
    Int J Oncol; 2003 Dec; 23(6):1593-9. PubMed ID: 14612931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
    Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors in progression of human esophageal and gastric carcinomas.
    Yoshida K; Yasui W; Ito H; Tahara E
    Exp Pathol; 1990; 40(4):291-300. PubMed ID: 2098274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Nma on growth inhibition by TGF-betaa in human gastric carcinoma cell lines.
    Sasaki T; Sasahira T; Shimura H; Ikeda S; Kuniyasu H
    Oncol Rep; 2004 Jun; 11(6):1219-23. PubMed ID: 15138559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.
    Fukuchi M; Masuda N; Miyazaki T; Nakajima M; Osawa H; Kato H; Kuwano H
    Cancer; 2002 Aug; 95(4):737-43. PubMed ID: 12209716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.
    Ge S; Zhang H; Deng T; Sun W; Ning T; Fan Q; Wang Y; Wang X; Zhang Q; Zhou Z; Yang H; Ying G; Ba Y
    Invest New Drugs; 2019 Oct; 37(5):923-934. PubMed ID: 30607520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.